S.Sreenivasa Rao's Insider Trades & SAST Disclosures
S.Sreenivasa Rao's most recent trade in Gland Pharma Ltd. was a Acquisition of 2,800 Equity Shares done at an average price of Rs. 542 . Disclosure was reported to the exchange on Feb. 26, 2025 under the SEBI (Prohibition of Insider Trading) Regulations, 2015.
No reported SAST transactions available for S.Sreenivasa Rao in the Trendlyne database.
| Stock | Client Name | Client Category | Action* | Reported To/By Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Period | Regulation (Insider/SAST) | Security Type | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gland Pharma | S SREENIVASA RAO | Designated Person | Acquisition | 26 Feb 2025 | 2,800 | 2,850 (0%) | 0.00% | 542 | 1,517,600 | 26 Feb 2025 26 Feb 2025 |
Insider Trading | Equity Shares | ESOP |
| Gland Pharma | S.Sreenivasa Rao | Designated Person | Acquisition | 12 Jul 2021 | 2,800 | 13,900 (0.01%) | 0.00% | 542 | 1,517,600 | 05 Jul 2021 05 Jul 2021 |
Insider Trading | Equity Shares | ESOP |
Acquisition (Buy): Purchase of shares
Disposal (Sell): Sale of shares
Pledge: Shares being used by promoters as collateral for loans. Usually a negative signal.
Revoke: When shares are released from a pledge. Usually a positive signal.
Invoke: When pledged shares are invoked by companies/banks who have provided the collateral, which may result in acquisition of stake in the company. Usually a negative signal.
Security Type: Share/ Warrants / Convertible Debentures
Kind of transaction Mode: Public rights/ preferential offer / off market / inter-se transfer/ Market Sale
Data as reported to BSE and NSE
Insider trading data is from Disclosure under SEBI (Prohibition of Insider Trading) Regulations, 2015.